NCT02412514View on ClinicalTrials.gov

Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules

PHASE4CompletedINTERVENTIONAL
Enrollment

456

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

bOPV (three dose)

bOPV administered at 6, 10, and 14 weeks of age.

BIOLOGICAL

bOPV (two dose)

bOPV administered at 10 and 14 weeks of age.

BIOLOGICAL

IPV

IPV administered at 6 weeks of age

Trial Locations (1)

Unknown

Mirpur Clinic (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT02412514 - Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules | Biotech Hunter | Biotech Hunter